Musculoskeletal
Anterior Cruciate Ligament Reconstruction
0
Pipeline Programs↗
8
Active Trials↗
0
Companies Involved↗
Anterior Cruciate Ligament Reconstruction is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
36
clinical trials
Completed21 · 58%
Unknown status5 · 14%
Recruiting4 · 11%
Not yet recruiting3 · 8%
Withdrawn1 · 3%
Active, not recruiting1 · 3%
Other1 · 3%
Clinical Trials
Trial Activity
36 trials
MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)
Recruiting·—·Phase 1·NCT04572256·30 enrolled
The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction.
Recruiting·—·N/A·NCT06442319·60 enrolled
Cyclops Syndrome After Anterior Cruciate Ligament Reconstruction
Active, not recruiting·GGCS Ramsay Santé pour l'Enseignement et la Recherche·Phase 3·NCT05008731·132 enrolled
Oral Melatonin With Intra Articular Analgesia on Pain After Arthroscopic Anterior Cruciate Ligament Reconstruction
Not yet recruiting·—·N/A·NCT07096635·50 enrolled
Local Infiltration Analgesia vs Adductor Canal Block for Analgesia After Anterior Cruciate Ligament Reconstruction
Completed·—·Phase 4·NCT02524652·104 enrolled
The Effect of Platelet Rich Plasma (PRP) on Post Operative Pain in Anterior Cruciate Ligament Reconstruction
Completed·—·Phase 4·NCT01765712·50 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)